Abstract:OBJECTIVE: Although atherosclerosis is described in New Zealand White rabbit's iliac artery, yet details of time-dependent atherosclerosis progression are not well known. Further, a well characterized accelerated model of atherosclerosis is also required for the screening of candidate drugs to target specific steps of atherosclerosis development. The present study extensively characterizes the time-dependent plaque composition and functional responses of the atherosclerosis in rabbit iliac artery and its modification by simvastatin.METHODS: Atherosclerosis was induced with a combination of balloon injury and atherogenic diet (AD) (1% cholesterol, 6% peanut oil) in rabbit's iliac artery. Atherosclerosis progression was evaluated on days 8, 10, 15, 21, 35, and 56 after AD feeding. The plaque characterization was done using histology, real-time reverse transcription-polymerase chain reaction, and vasoreactivity experiments. The standard anti-hyperlipidemic drug, simvastatin (5 mg·kg·d), was used to investigate its effect on atherosclerotic changes.RESULTS: Plasma lipids were elevated in a progressive manner after AD feeding from days 8 to 56. Similarly, arterial lipids, Monocyte Chemoattractant Protein-1 (MCP-1) level along with infiltration of macrophages in the lesion area were also increased from day 15 onward. This resulted in a significant increase in the plaque area and intimal-medial thickness ratio in contrast to normal animals. Inflammatory milieu was observed with a significant increase in expression of pro-inflammatory regulators like MCP-1, Tumor Necrosis Factor-α (TNF-α) and Vascular Cell Adhesion Molecule-1 (VCAM-1), whereas anti-inflammatory cytokine interleukin 10 decreased as disease progressed. Endothelial dysfunction was also observed, specifically Acetylcholine (ACh)-induced vasorelaxation was reduced from day 8 onward, whereas the phenylephrine-induced vasoconstriction response was progressively reduced from day 15 in the iliac artery. Ground substances including proteoglycans, α-actin, and collagen content along with metalloproteinase-9 and Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibitors were significantly augmented at later time points, day 21 onward. Simvastatin treatment for 35 days, at a dose having no significant effect on plasma lipid levels, significantly reduced atherosclerotic progression as evident by reduced macrophage content, inflammatory burden, and extracellular matrix component like proteoglycans and metalloproteinase-9.CONCLUSIONS: The authors observed that AD feeding with balloon injury in the rabbit iliac artery accelerated the progression of atherosclerosis and exhibited predominant features of type III human lesion within 8 weeks (56 days). Simvastatin treatment for 35 days exhibited anti-atherosclerotic efficacy without significantly lowering the circulating lipids. The current study thus provides an insight into the time-dependent atherosclerotic progression in rabbit iliac artery and highlights its utility for anti-atherosclerotic evaluation of the candidate drugs.

Effect of simvastatin on expression of carnitine patmitoyl transferase-1 in vascular smooth muscle layer of atherosclerotic rabbits

Effect of simvastatin on expression of glucose transporter-4mRNA in vascular smooth muscle layer of atherosclerotic rabbits

Effects of Simvastatin in A Rabbit Model of Atherosclerosis: Role of Ho-1/Co-Cgmp Pathway and Related Anti-Oxidative Enzyme Expression

Studies on the Simvastatin Effect on the Artery of Atherosclerotic Rabbit Using Proteomics Approaches

Effect of Simvastatin on Expression of Tissue Inhibitor of Matrix Metalloproteinase-1 in Iliac Artery of Atherosclerotic Rabbits

Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model

Simvastatin Reduces Expression and Activity of Lipoprotein-Associated Phospholipase A(2) in the Aorta of Hypercholesterolaemic Atherosclerotic Rabbits.

Effect of atorvastatin on matrix metalloproteinase 9 expression in the upstream shoulder of aortic atherosclerotic plaques in rabbits

Carnitine Palmitoyltransferase-Ⅰ mRNA Downregulated in Vascular Smooth Muscle Tissue of Rabbit During Atherosclerosis

Inhibition of Atherosclerosis Progression, Intimal Hyperplasia, and Oxidative Stress by Simvastatin and Ivabradine May Reduce Thoracic Aorta’s Stiffness in Hypercholesterolemic Rabbits

Regulatory effect of herbal cake-partitioned moxibustion on cholesterol reverse transport nuclear receptor LXRα in rabbits with atherosclerosis

Simvastatin Reduces Connexin43 Expression and Inhibits Rabbit Atherosclerotic Lesion Formation

Endothelin-1 and cyclooxygenase-2 expression in rabbit atherosclerotic plaques

Study of Component Compatibility from Qixue Bingzhi Recipe in Preventing and Treating Rabbit Arteriosclerosis

Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin

Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.

Effect of Simvastatin on the Proliferation and Migration of Vascular Smooth Muscle Cells

Effects of long-time simvastatin-treated on bile acids homeostasis and relative gene expressions in hypercholesterolemia mice

Carnitine Supplement Inhibits the Increase of the Level of Serum Lipids in Hyperlipemia Rabbits

Study of effect of pravastatin on apoptosis in vulnerable plaques in abdominal aorta in model rabbits

Effect of Pravastatin on Arterial Gene Expression of Plasminogen Activator Inhibitor Type 1 in Atherosclerotic Rabbits